Candida albicans Infection Disrupts the Metabolism of Vaginal Epithelial Cells and Inhibits Cellular Glycolysis
Open Access
- 30 January 2024
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 12 (2) , 292
Abstract
Vulvovaginal candidiasis (VVC) is a common gynecologic disorder caused by fungal infections of the vaginal mucosa, with the most common pathogen being Candida albicans (C. albicans). Exploring metabolite changes in the disease process facilitates further discovery of targets for disease treatment. However, studies on the metabolic changes caused by C. albicans are still lacking. In this study, we used C. albicans-infected vaginal epithelial cells to construct an in vitro model of VVC, analyzed the metabolites by UHPLC-Q-Exactive MS, and screened the potential metabolites based on metabolomics. The results showed that C. albicans infection resulted in significant up-regulation of D-arabitol, palmitic acid, adenosine, etc.; significant down-regulation of lactic acid, nicotinamide (NAM), nicotinate (NA), etc.; and disruption of amino acid metabolism, and that these significantly altered metabolites might be potential therapeutic targets of VVC. Further experiments showed that C. albicans infection led to a decrease in glycolytic enzymes in damaged cells, inhibiting glycolysis and leading to significant alterations in glycolytic metabolites. The present study explored the potential metabolites of VVC induced by C. albicans infection based on metabolomics and verified the inhibitory effect of C. albicans on vaginal epithelial cell glycolysis, which is valuable for the diagnosis and treatment of VVC.Keywords
Funding Information
- Science and Technology Department of Guizhou Province ([2021]414)
This publication has 39 references indexed in Scilit:
- A Comprehensive Analysis of Metabolomics and Transcriptomics in Cervical CancerScientific Reports, 2017
- Human vaginal epithelial cells augment autophagy marker genes in response to Candida albicans infectionAmerican Journal of Reproductive Immunology, 2017
- Lactobacillus crispatus Modulates Vaginal Epithelial Cell Innate Response to Candida albicansChinese Medical Journal, 2017
- Vulvovaginal candidiasis: Epidemiology, microbiology and risk factorsCritical Reviews in Microbiology, 2015
- Treatment of vulvovaginal candidiasis: a review of the literatureActa Dermatovenerologica Alpina Pannonica et Adriatica, 2015
- Normalization of CD4 + T cell metabolism reverses lupusScience Translational Medicine, 2015
- Vulvovaginal Candida albicans infections: pathogenesis, immunity and vaccine prospectsBJOG: An International Journal of Obstetrics & Gynaecology, 2014
- Immunity, inflammation and cancer: a leading role for adenosineNature Reviews Cancer, 2013
- A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)aClinical Infectious Diseases, 2013
- Probiotic Interference ofLactobacillus rhamnosusGR-1 andLactobacillus reuteriRC-14 with the Opportunistic Fungal PathogenCandida albicansInfectious Diseases in Obstetrics and Gynecology, 2012